Dechra is a global specialist in veterinary pharmaceuticals and related products business, founded in 1997. The company's key focus is on the development, manufacture, and sales of high-quality products exclusively for veterinarians worldwide. With sales and marketing organizations in 26 countries and products marketed in 63 other countries through distributors or marketing partners, Dechra has a wide global reach. The company's dedication to sustainable improvement of global animal health and welfare is highlighted in its slogan, "Global specialist in veterinary pharmaceuticals and related products business." Dechra stands out by seeing things from The Veterinary Perspective, understanding the challenges veterinarians face, and providing necessary training, support, and information to help them better support animals. The company's business model is customer-centric, ensuring that veterinarians have access to everyday evidence-based treatments and knowledge on rarer diseases. This approach has positioned Dechra as a preferred supplier and has contributed to its continuous growth. The company's commitment to the veterinary profession and its extensive presence in the global market make it an interesting potential investment opportunity for venture capitalists looking to tap into the growing veterinary pharmaceuticals and related products sector. For more information about Dechra, visit their company website at www.dechra.com.
There is no investment information
No recent news or press coverage available for Dechra.